![Enhancing post – operative treatment for pancreatic ductal adenocarcinoma through AI](https://oncodaily.com/pub/uploads/2024/08/IMG_4946-1280x720.jpeg)
Photo taken from newstoday.com
Sep 1, 2024, 08:12
Enhancing post – operative treatment for pancreatic ductal adenocarcinoma through AI
Nelson Dusetti posted on X:
“We are very grateful to Davide Melisi for the thoughtful editorial and to Annals of Oncology for featuring our work.
Circumventing human limits in precision oncology: AI-enhanced tailoring of post-operative treatment for pancreatic ductal adenocarcinoma.”
Source: Nelson Dusetti/X
Authors: S. Casalino, C. Zecchetto, V. Merz, A. Quinzii, S. Pietrobono, and D. Melisi.
Nelson Dusetti is the Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023